Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.67 |
| ▸ | MAPT | P10636 | 7/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.67 |
| ▸ | RXRA | P19793 | 5/20 | 0.67 |
| ▸ | RARA | P10276 | 4/20 | 0.67 |
| ▸ | RARB | P10826 | 4/20 | 0.67 |
| ▸ | RARG | P13631 | 4/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.67 |
| ▸ | APP | P05067 | 4/20 | 0.67 |
| ▸ | SNCA | P37840 | 4/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.67 |
| ▸ | RXRB | P28702 | 2/20 | 0.67 |
| ▸ | RXRG | P48443 | 2/20 | 0.67 |
| ▸ | RORC | P51449 | 2/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.67 |
| ▸ | HTR2B | P41595 | 2/20 | 0.67 |
| ▸ | BLM | P54132 | 2/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14300778 | 1.00 | ALDH1A1 (0.67) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL21427636 | 1.00 | ALDH1A1 (0.67) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL14161069 | 1.00 | ALDH1A1 (0.67) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL14164136 | 1.00 | ALDH1A1 (0.67) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL4898397 | 0.90 | ALDH1A1 (0.72) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL4784917 | 0.90 | ALDH1A1 (0.72) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL8648149 | 0.90 | ALDH1A1 (0.72) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL8631847 | 0.90 | ALDH1A1 (0.72) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL4892803 | 0.90 | ALDH1A1 (0.72) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL342404 | 0.90 | ALDH1A1 (0.72) | ALDH1A1MAPTCYP3A4RXRARARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087103-A1 | COMBINATION OF RETINOL, ALKYLAMIDOTHIAZOLES AND FLAVONOIDS FOR IMPROVING ACTIVE SUBSTANCE STABILIZATION | BEIERSDORF AG (DE) | 2026-04-30 | — | — | WO | claimed |
| EP-4701742-A1 | RETINOL-CONTAINING COSMETIC PREPARATION WITH GOOD SKIN COMPATIBILITY | Beiersdorf AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4701615-A1 | RETINOL-CONTAINING COSMETIC PREPARATION HAVING GOOD STABILITY AND SKIN COMPATIBILITY | Beiersdorf AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4701743-A1 | RETINOL-CONTAINING COSMETIC PREPARATION WITH GOOD STABILITY, SKIN COMPATIBILITY AND EFFECTIVENESS | Beiersdorf AG (DE) | 2026-03-04 | — | — | EP | claimed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | claimed |
| EP-4110276-B1 | COMPOSITIONS COMPRISING ALKANEDIOLS | SYMRISE AG (DE) | 2026-01-28 | — | — | EP | claimed |
| US-12440436-B1 | Face peel formulation and method of application | Platinum Skin Care, Inc. (US) | 2025-10-14 | — | — | US | claimed |
| EP-4622621-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | Symrise AG (DE) | 2025-10-01 | — | — | EP | claimed |
| EP-4565194-A1 | ODOR AND COLORANT STABILIZED COMPOSITIONS | Symrise AG (DE) | 2025-06-11 | — | — | EP | claimed |
| EP-4477264-A2 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ACTIVE INGREDIENTS | Symrise AG (DE) | 2024-12-18 | — | — | EP | claimed |
| CN-118662385-A | Hydroxy pinacolone retinoic acid ester nanoemulsion and preparation method and application thereof | 北京炜烨创新科技有限公司 | 2024-09-20 | — | — | CN | claimed |
| WO-2024110515-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2024-05-30 | — | — | WO | claimed |
| WO-2024028513-A1 | ODOR AND COLORANT STABILIZED COMPOSITIONS | SYMRISE AG (DE) | 2024-02-08 | — | — | WO | claimed |
| WO-2024027931-A1 | ODOR AND COLORANT STABILIZED COMPOSITIONS | SYMRISE AG (DE) | 2024-02-08 | — | — | WO | claimed |
| US-20230338250-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Active Ingredients | SYMRISE AG (DE) | 2023-10-26 | — | — | US | claimed |
| EP-4146155-A1 | CANNABINOID-COMPRISING COSMETIC COMPOSITIONS | This Works Products Limited (GB) | 2023-03-15 | — | — | EP | claimed |
| US-20230049319-A1 | CANNABINOID-COMPRISING COSMETIC COMPOSITIONS | THIS WORKS PRODUCTS LIMITED (GB) | 2023-02-16 | — | — | US | claimed |
| EP-4110276-A1 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ACTIVE INGREDIENTS | Symrise AG (DE) | 2023-01-04 | — | — | EP | claimed |
| WO-2022122140-A1 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ACTIVE INGREDIENTS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| WO-2022122935-A1 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ACTIVE INGREDIENTS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | ALDH1A1 156/4885MAPT 781/4885CYP3A4 2860/4885 |
| US-20230338250-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Active Ingredients | DERL1, DHCR7, DHCR24 | ALDH1A1 54/4885MAPT 1166/4885CYP3A4 1783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.